UnitedHealth Group Incorporated $UNH Stock Purchased by Bank Pictet & Cie Europe AG

Bank Pictet & Cie Europe AG lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% in the third quarter, HoldingsChannel reports. The firm owned 196,988 shares of the healthcare conglomerate’s stock after buying an additional 3,384 shares during the period. UnitedHealth Group makes up about 1.4% of Bank Pictet & Cie Europe AG’s portfolio, making the stock its 20th biggest holding. Bank Pictet & Cie Europe AG’s holdings in UnitedHealth Group were worth $72,310,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Corient Private Wealth LP acquired a new position in UnitedHealth Group in the 2nd quarter valued at about $245,516,000. Legal & General Group Plc acquired a new stake in shares of UnitedHealth Group during the 2nd quarter worth approximately $2,444,928,000. Jupiter Topco LLC purchased a new stake in shares of UnitedHealth Group during the 2nd quarter valued at approximately $2,019,844,000. BlackRock Inc. lifted its holdings in UnitedHealth Group by 4.6% in the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after acquiring an additional 3,395,530 shares during the last quarter. Finally, Canada Pension Plan Investment Board purchased a new position in UnitedHealth Group in the second quarter worth approximately $971,757,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.19% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research firms have commented on UNH. Wall Street Zen upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Weiss Ratings upgraded UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, October 8th. Oppenheimer raised their price objective on UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a research report on Friday, July 17th. Robert W. Baird decreased their target price on shares of UnitedHealth Group from $453.00 to $427.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 14th. Finally, Sanford C. Bernstein lowered their target price on shares of UnitedHealth Group from $512.00 to $500.00 and set an “outperform” rating for the company in a research note on Wednesday, October 14th. Twenty research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $463.57.

UnitedHealth Group Trading Up 3.7%

NYSE:UNH traded up $15.19 on Tuesday, reaching $422.07. 3,613,438 shares of the company’s stock were exchanged, compared to its average volume of 7,366,441. The firm has a market capitalization of $378.85 billion, a price-to-earnings ratio of 24.07, a price-to-earnings-growth ratio of 1.45 and a beta of 0.60. UnitedHealth Group Incorporated has a 52-week low of $255.96 and a 52-week high of $461.62. The company has a quick ratio of 0.78, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The business has a fifty day moving average of $387.04 and a 200-day moving average of $386.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating the consensus estimate of $4.14 by $0.55. The business had revenue of $112.70 billion during the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The business’s revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter last year, the firm posted $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 20.64 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were paid a $2.32 dividend. This represents a $9.28 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Monday, September 14th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 53.00%.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Quarterly earnings beat expectations: UnitedHealth reported third-quarter adjusted EPS of $4.69, exceeding the $4.14 consensus estimate, while revenue reached $112.7 billion versus expectations of $111.31 billion. Management also raised its 2026 adjusted EPS outlook to at least $20.50. UnitedHealth Group Has The Market Asking A Bigger Question
• Positive Sentiment: Investor and analyst interest has improved: The earnings beat and higher outlook have renewed attention around medical-cost trends and contributed to stronger recent momentum in the shares. A CNBC “Halftime Report” panelist also selected UNH as a preferred trade following the results. Twilio, Transocean and a Health Care Stock on CNBC’s Final Trades
• Positive Sentiment: Healthcare-sector exposure remains attractive: Analysts are highlighting healthcare ETFs that include UnitedHealth, offering investors diversified exposure while reducing reliance on any single insurer or Medicaid-related business. Healthcare ETFs to Buy as UnitedHealth Beats on Q3 Earnings

UnitedHealth Group Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.